STOCK TITAN
  1. Home
  2. Sec-filings
  3. CRWV
  4. [144] CoreWeave, Inc. SEC Filing

CRWV (NASDAQ: CRWV) insider plans 25,000-share Rule 144 stock sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CRWV reports a planned Rule 144 sale of 25,000 common shares, with an aggregate market value of $2,329,750.00. These shares are founder shares acquired on February 25, 2019 directly from the issuer, with full payment made that same day.

The notice states that 386,401,201 common shares were outstanding, and the proposed sale is to be executed through Morgan Stanley Smith Barney LLC on the NASDAQ exchange around February 2, 2026. The filing also lists extensive recent sales under Rule 10b5-1 trading plans by Brannin McBee-related trusts and entities, including a non-affiliate donee sale of 257,733 shares for $19,592,527.61 during the prior three months.

Positive

  • None.

Negative

  • None.

Insights

CRWV insider-affiliated holders file for additional liquidity under Rule 144.

The notice covers a proposed Rule 144 sale of 25,000 CRWV common shares, labeled as founder shares acquired from the issuer in 2019. The broker is Morgan Stanley Smith Barney LLC, and the shares trade on NASDAQ, indicating a standard secondary-market liquidity move.

The table of prior three-month activity shows repeated Rule 10b5-1 sales by Brannin McBee and multiple related trusts, plus a non-affiliate donee sale of 257,733 shares for $19,592,527.61. These are selling stockholder transactions; they do not raise new capital for the issuer, and their ultimate impact depends on ongoing trading volumes and market absorption.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR

FAQ

What does the Form 144 filing for CRWV disclose about upcoming share sales?

The Form 144 shows a planned sale of 25,000 CRWV common shares, classified as founder shares. They were acquired from the issuer in 2019 and have an aggregate market value of about $2.33 million, to be sold on NASDAQ through Morgan Stanley Smith Barney LLC.

How many CRWV shares are covered by the new Rule 144 sale notice?

The notice covers 25,000 CRWV common shares proposed for sale. These founder shares were acquired on February 25, 2019 from the issuer, with full payment made that day, and are planned to be sold via Morgan Stanley Smith Barney LLC on NASDAQ.

What is the aggregate market value of the CRWV shares in the new Form 144?

The Form 144 lists an aggregate market value of $2,329,750.00 for the 25,000 CRWV common shares to be sold. This figure reflects the market price used in the notice for the proposed Rule 144 transaction through Morgan Stanley Smith Barney LLC on NASDAQ.

How many CRWV shares were outstanding when the Rule 144 notice was filed?

The filing reports 386,401,201 CRWV common shares outstanding. This figure provides context for the planned 25,000-share Rule 144 sale and the previously executed 10b5-1 sales by related trusts and entities over the prior three months.

Who is the broker handling the planned CRWV Rule 144 share sale?

The planned sale of 25,000 CRWV common shares will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s listed office is at 1 New York Plaza, 8th Floor, New York, NY 10004, and the shares are to be sold on NASDAQ.